Celldex Therapeutics, Inc.
(NASDAQ : CLDX)

( )
CLDX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corp.
0.10%108.241.3%$1607.19m
AMGNAmgen, Inc.
1.02%227.821.3%$571.14m
BIIBBiogen, Inc.
1.07%288.461.4%$565.61m
GILDGilead Sciences, Inc.
1.31%65.731.0%$410.71m
ILMNIllumina, Inc.
-0.65%312.853.5%$332.16m
VRTXVertex Pharmaceuticals, Inc.
0.20%215.501.9%$314.83m
REGNRegeneron Pharmaceuticals, Inc.
1.90%350.782.6%$287.08m
EXASEXACT Sciences Corp.
-5.85%79.0224.0%$211.83m
ALXNAlexion Pharmaceuticals, Inc.
0.92%109.532.0%$182.47m
BMRNBioMarin Pharmaceutical, Inc.
-0.47%77.074.3%$133.99m
SRPTSarepta Therapeutics, Inc.
1.83%104.1714.6%$129.42m
SGENSeattle Genetics, Inc.
-0.78%119.906.1%$124.30m
AAgilent Technologies, Inc.
-0.28%78.301.6%$105.86m
BGNEBeiGene Ltd.
2.47%208.342.1%$96.02m
NBIXNeurocrine Biosciences, Inc.
0.59%113.755.0%$93.68m

Company Profile

Celldex Therapeutics, Inc. engages in the research, development, and commercialization of immunotherapies and other targeted biologics. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.